Lukas Werner

Prague, PR, Czech Republic

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Targeting Cellular Senescence as a Therapeutic Strategy to Attenuate Pulmonary Fibrosis Associated with Metabolic Syndrome.

Targeting Cellular Senescence as a Therapeutic Strategy to Attenuate Pulmonary Fibrosis Associated with Metabolic Syndrome.

Journal: Aging and disease

Published: January 31, 2026

Modular Design of Mitochondrion-Targeted Iron Chelators Allows Highly Selective Antiparasitic Activity against Trypanosomes and Apicomplexan Parasites.

Modular Design of Mitochondrion-Targeted Iron Chelators Allows Highly Selective Antiparasitic Activity against Trypanosomes and Apicomplexan Parasites.

Journal: ACS infectious diseases

Published: December 22, 2025

Quantitative Office-Based Laryngoscopy: Bench Validation of a Simple Calibration Method for Submillimeter Accuracy With a Clinical-Grade Stereo-Laryngoscope.

Quantitative Office-Based Laryngoscopy: Bench Validation of a Simple Calibration Method for Submillimeter Accuracy With a Clinical-Grade Stereo-Laryngoscope.

Journal: Journal of voice : official journal of the Voice Foundation

Published: December 02, 2025

Moth-Eye-Inspired Antireflective Structures in Hybrid Polymers: Depth-Variable Etching Techniques, Optical Performance, Thermal Stability, and Hydrophobicity.

Moth-Eye-Inspired Antireflective Structures in Hybrid Polymers: Depth-Variable Etching Techniques, Optical Performance, Thermal Stability, and Hydrophobicity.

Journal: Nanomaterials (Basel, Switzerland)

Published: February 21, 2025

Role of ANT2 in mitochondrial function and cancer cell survival: a target for therapeutic intervention.

Role of ANT2 in mitochondrial function and cancer cell survival: a target for therapeutic intervention.

Journal: Cell death discovery

Published: November 28, 2024

Targeting Mitochondrial Integrity as a New Senolytic Strategy.

Targeting Mitochondrial Integrity as a New Senolytic Strategy.

Journal: Aging and disease

Published: August 31, 2024

NDRG1 acts as an oncogene in triple-negative breast cancer and its loss sensitizes cells to mitochondrial iron chelation.

NDRG1 acts as an oncogene in triple-negative breast cancer and its loss sensitizes cells to mitochondrial iron chelation.

Journal: Frontiers in pharmacology

Published: April 23, 2024

Chelation of Mitochondrial Iron as an Antiparasitic Strategy.

Chelation of Mitochondrial Iron as an Antiparasitic Strategy.

Journal: ACS infectious diseases

Published: January 30, 2024

MitoTam-01 Trial: Mitochondrial Targeting as Plausible Approach to Cancer Therapy. Comment on Yap et al. Complex I Inhibitor of Oxidative Phosphorylation in Advanced Solid Tumors and Acute Myeloid Leukemia: Phase I Trials. Nat. Med. 2023, 29, 115-126.

MitoTam-01 Trial: Mitochondrial Targeting as Plausible Approach to Cancer Therapy. Comment on Yap et al. Complex I Inhibitor of Oxidative Phosphorylation in Advanced Solid Tumors and Acute Myeloid Leukemia: Phase I Trials. Nat. Med. 2023, 29, 115-126.

Journal: Cancers

Published: July 18, 2023

Mitochondrially targeted tamoxifen as anticancer therapy: case series of patients with renal cell carcinoma treated in a phase I/Ib clinical trial.

Mitochondrially targeted tamoxifen as anticancer therapy: case series of patients with renal cell carcinoma treated in a phase I/Ib clinical trial.

Journal: Therapeutic advances in medical oncology

Published: March 28, 2023

The 4-Aminomethylphenoxy-Benzoxaborole AN3057 as a Potential Treatment Option for Primary Amoebic Meningoencephalitis.

The 4-Aminomethylphenoxy-Benzoxaborole AN3057 as a Potential Treatment Option for Primary Amoebic Meningoencephalitis.

Journal: Antimicrobial agents and chemotherapy

Published: January 23, 2023

Mitochondrially targeted tamoxifen in patients with metastatic solid tumours: an open-label, phase I/Ib single-centre trial.

Mitochondrially targeted tamoxifen in patients with metastatic solid tumours: an open-label, phase I/Ib single-centre trial.

Journal: EClinicalMedicine

Published: October 04, 2022

Showing 1-12 of 21

Last Updated: 09/26/2026